Projects per year
Personal profile
Education
- 1995 PhD, Department of Pharmacy, University of Manchester
Experience
- 1988/10 ~ 1990/06 Teaching Assistant, School of Pharmacy, National Defense Medical Center
- 1996/02 ~ 1997/03 Lecturer, Institute of Clinical Pharmacy, National Cheng Kung University
- 1997/03 ~ 2000/07 Assistant Professor, Institute of Clinical Pharmacy, National Cheng Kung University
- 2000/08 ~ 2011/07 Associate Professor, Institute of Clinical Pharmacy, National Cheng Kung University
- 2011/08~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
Research Interests
- 藥物動力學
- 藥物定量分析
- 定量藥理學
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Chen-Hsi Chou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 16 Finished
-
Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting
Chang, H. M., Chou, C. H. & Tsai, H. C., 2022 Dec, In: BMC infectious diseases. 22, 1, 2.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”
Chou, C. H. & Hsu, L. F., 2021 Jul, In: European Journal of Clinical Pharmacology. 77, 7, p. 1067-1068 2 p.Research output: Contribution to journal › Letter › peer-review
-
Model-based simulation to support the extended dosing regimens of atezolizumab
Chou, C. H. & Hsu, L. F., 2021 Jan, In: European Journal of Clinical Pharmacology. 77, 1, p. 87-93 7 p.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
Outcomes after switching to BIC/FTC/TAF in patients with virological failure to protease inhibitors or non-nucleoside reverse transcriptase inhibitors: A real-world cohort study
Chang, H. M., Chou, P. Y., Chou, C. H. & Tsai, H. C., 2021, In: Infection and Drug Resistance. 14, p. 4877-4886 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation
Juang, S. H., Hsieh, M. T., Hsu, P. L., Chen, J. L., Liu, H. K., Liang, F. P., Kuo, S. C., Chiu, C. Y., Liu, S. H., Chou, C. H., Wu, T. S. & Hung, H. Y., 2021 Jan 1, In: Molecules. 26, 1, 164.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)